Baird Financial Group, Inc. - COGNITION THERAPEUTICS INC ownership

COGNITION THERAPEUTICS INC's ticker is and the CUSIP is 19243B102. A total of 37 filers reported holding COGNITION THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of COGNITION THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,246
-21.3%
22,3930.0%0.00%
Q2 2023$40,979
-7.6%
22,3930.0%0.00%
Q1 2023$44,338
+105466.7%
22,393
+11.4%
0.00%
Q4 2022$42
-99.9%
20,093
-50.7%
0.00%
Q3 2022$77,000
+79.1%
40,786
+100.0%
0.00%
Q2 2022$43,000
-23.2%
20,3930.0%0.00%
Q1 2022$56,00020,3930.00%
Other shareholders
COGNITION THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,038,853$2,935,9481.39%
Worth Venture Partners, LLC 508,719$732,5550.44%
AMERICAN FINANCIAL GROUP INC 205,000$2950.10%
CASTLE WEALTH MANAGEMENT LLC 43,380$62,4680.04%
CARLSON CAPITAL L P 290,000$417,6000.03%
FCA CORP /TX 51,471$74,1180.03%
PATHSTONE FAMILY OFFICE, LLC 2,205,377$3,175,7430.02%
Neumann Capital Management, LLC 33,382$48,0700.02%
Steward Financial Group LLC 40,874$580.02%
Perigon Wealth Management, LLC 223,500$321,8400.01%
View complete list of COGNITION THERAPEUTICS INC shareholders